Evidence map›Paper›PMID 38482043›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2024

Effects of Combining Music Therapy, Light Therapy, and Chromotherapy in the Treatment of Chronic Pain Patients: A Pilot Study.

Alcira Suarez, Yannick Delgado, Alain Servais, Nicolas Verardi, Delphine Durand, Severine Litaneur, Vincent Wyart, Julien Nizard, Jean-Paul Nguyen

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Effects of 440-HzPeerJ · 2025
    Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alcira SuarezPain Assessment and Treatment Center (CETD), Clinique Bretéché, Elsan Group, Nantes 44000, France.
Yannick DelgadoSociété DYCOM SAS, Saint-Herblain 44800, France.
Alain ServaisSociété DYCOM SAS, Saint-Herblain 44800, France.
Nicolas VerardiPain Assessment and Treatment Center (CETD), Clinique Bretéché, Elsan Group, Nantes 44000, France.
Delphine DurandPain Assessment and Treatment Center (CETD), Clinique Bretéché, Elsan Group, Nantes 44000, France.
Severine LitaneurPain Assessment and Treatment Center (CETD), Clinique Bretéché, Elsan Group, Nantes 44000, France.
Vincent WyartSanté Atlantique, Elsan Group, Nantes, France.
Julien NizardCETD CHU (University Hospital) Laennec, Nantes, France.
Jean-Paul NguyenPain Assessment and Treatment Center (CETD), Clinique Bretéché, Elsan Group, Nantes 44000, France.ORCID https://orcid.org/0000-0003-3313-5991
Hospices Civils de Lyon · FRInstitut Génétique Nantes Atlantique · FRIMT Atlantique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It is currently considered that around 30% of chronic pain patients are totally refractory to medical treatment. Among patients who remain responsive to medical treatment, it is estimated that between 20% and 50% are likely to discontinue treatment due to severe side effects. Given these therapeutic difficulties, a significant number of patients turn to complementary therapies. Objective: The LineQuartz® is a medical device that combines 3 complementary therapies, namely, music therapy, light therapy, and chromotherapy. We propose to evaluate its effectiveness in chronic pain patients. Methods: Between October 2021 and October 2022, 44 patients aged between 23 and 85 years (mean: 55.4 years) were included in a prospective study. All patients had background pain intensity greater than 4/10 on the Numerical Pain Scale (NS). Treatment consisted of 4 half-hour sessions, divided into one session per week for 3 weeks (21 days). Patients were assessed by the Brief Pain Inventory (BPI) and the Hospital Anxiety and Depression scale (HAD) the day before starting treatment (Day 0) and the day after the end of treatment (Day 22). Results: Apart from the BPI item, "relationship with others," all items improved significantly (

Identifiers

PMID38482043
PMCPMC10937082
OpenAlexW4392756789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.